HelixHood combines Bio Protocol mechanics with autonomous AI agents on Robinhood Chain, turning complex DeSci research into accessible, liquid crypto assets for retail.
Institutional gatekeeping and scientific jargon have kept the upside of longevity and health-tech research locked away. HelixHood's agents close that gap end to end.
Biotech IP sits behind VCs and pharma, out of reach for individual investors.
Promising longevity science stalls for years chasing traditional grant cycles.
Dense clinical literature is unreadable to anyone without a research background.
AI agents parse scientific publications continuously and score biotech IP viability.
Longevity and health-tech research becomes a liquid, tradeable on-chain asset.
Yield and liquidity are routed automatically through Robinhood Chain.
Each HelixHood agent handles a distinct stage of turning locked research into a tradeable, risk-scored asset.
AI reasoning models analyze global medical publications and score biotech IP for commercial and scientific viability.
Sub-second agentic portfolio balancing and limit-order execution, natively routed through Robinhood Chain.
Longevity and health-tech research is converted into liquid, tradeable assets accessible to any retail wallet.
Automated anti-rug checks, holder distribution analysis, and live risk scoring built for retail traders.
A three-stage pipeline moves data from the open literature to an executed on-chain position, in that order.
AI agents continuously parse global medical research and DeSci protocol feeds for new IP.
A Hermes-style reasoning engine converts raw findings into scored, actionable trading signals.
Signals become on-chain transactions, routed seamlessly through Robinhood Chain.
The HelixHood token coordinates the agents, the liquidity, and the research pipeline that sit underneath the protocol.
Stakers back the reasoning agents that read, score, and route new biotech IP. Rewards scale with agent accuracy and uptime.
LPs supply capital against curated biotech assets, earning yield generated by trading activity and agent-managed rebalancing.
Token holders govern curation thresholds, risk parameters, and which DeSci research categories agents prioritize next.